Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -1.45% is 93% above its 5-year average of -21.89%, near the high end of its 5-year range (-459.57%–20.34%).
96.82% above its 12-month average of -45.65%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -106.35%.
OPERATING MARGIN
-1.45%
OPERATING MARGIN AVG TTM
-45.65%
OPERATING MARGIN AVG 3Y
6.25%
OPERATING MARGIN AVG 5Y
-21.89%
OPERATING MARGIN AVG 10Y
-178.15%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+96.82%
CURRENT VS 3Y AVG
-123.20%
CURRENT VS 5Y AVG
+93.38%
CURRENT VS 10Y AVG
+99.19%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 389 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioStem Technologies, Inc.
Market Cap
$46.79M
Operating Margin
-1.45%
TTM Avg
-45.65%
3Y Avg
6.25%
5Y Avg
-21.89%
Market Cap
$49.50M
Operating Margin
-230.92%
TTM Avg
-150.83%
3Y Avg
-322.13%
5Y Avg
-477.29%
Market Cap
$49.96M
Operating Margin
-11541.50%
TTM Avg
-10608.91%
3Y Avg
-9412.76%
5Y Avg
-9062.71%
Market Cap
$50.25M
Operating Margin
-9240.66%
TTM Avg
-8899.44%
3Y Avg
-6820.53%
5Y Avg
-4916.43%
Market Cap
$50.51M
Operating Margin
-111.45%
TTM Avg
-10696.13%
3Y Avg
-10482.04%
5Y Avg
-431164.93%
Market Cap
$51.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$42.41M
Operating Margin
-163.94%
TTM Avg
-188.75%
3Y Avg
-214.75%
5Y Avg
-271.10%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | $46.79M | -1.45% | -45.65% | 6.25% | -21.89% |
| biote Corp. (BTMD)vs › | $49.40M | 18.50% | 17.27% | 3.29% | 10.87% |
| Celularity Inc. (CELU)vs › | $49.50M | -230.92% | -150.83% | -322.13% | -477.29% |
| Clene Inc. (CLNN)vs › | $49.96M | -11541.50% | -10608.91% | -9412.76% | -9062.71% |
| Envoy Medical, Inc. (COCH)vs › | $50.25M | -9240.66% | -8899.44% | -6820.53% | -4916.43% |
| Apollomics, Inc. (APLM)vs › | $50.51M | -111.45% | -10696.13% | -10482.04% | -431164.93% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| DarioHealth Corp. (DRIO)vs › | $42.41M | -163.94% | -188.75% | -214.75% | -271.10% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Filana Therapeutics, Inc. (FLNA)vs › | $42.02M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
93.1%
Operating Margin
-1.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -106.35% |
| 2026-03-31 | -144.80% |
| 2025-12-31 | 8.84% |
| 2025-09-30 | 13.83% |
| 2025-06-30 | 0.23% |
| 2025-03-31 | 7.24% |
| 2024-12-31 | 8.24% |
| 2024-09-30 | 11.26% |
| 2024-06-30 | 11.84% |
| 2024-03-31 | 11.00% |
| 2023-12-31 | -24.70% |
| 2023-09-30 | 14.72% |
| 2023-06-30 | -253.97% |
| 2023-03-31 | -275.36% |
| 2022-12-31 | -459.57% |
| 2022-09-30 | -67.64% |
| 2022-06-30 | 20.34% |
| 2022-03-31 | -24.48% |
| 2021-12-31 | -43.81% |
| 2021-09-30 | -64.29% |
| 2021-06-30 | -25.54% |
| 2021-03-31 | -36.02% |
| 2020-12-31 | -41.92% |
| 2020-09-30 | -126.14% |
| 2020-06-30 | -238.65% |
| 2020-03-31 | -32.98% |
| 2019-12-31 | -36.49% |
| 2019-09-30 | -172.35% |
| 2019-06-30 | -277.67% |
| 2019-03-31 | -426.74% |
| 2018-12-31 | -727.14% |
| 2018-09-30 | -445.18% |
| 2018-06-30 | -2515.98% |
| 2018-03-31 | -1981.92% |
| 2017-12-31 | -226.88% |
| 2017-09-30 | -2869.83% |
| 2017-06-30 | -1957.24% |
| 2017-03-31 | -1047.06% |
| 2016-12-31 | 1937.53% |
| 2016-09-30 | -1172.75% |
| 2016-06-30 | -1017.20% |
| 2016-03-31 | -327.83% |
| 2015-12-31 | -646.76% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | -62.36% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 28.86% |
| 2013-06-30 | 0.00% |
| 2013-03-31 | 0.00% |
